James Curtis, PhD

Dow Corning Corporation


An SFB member for over 25 years, Jim was the 2016 recipient of the C. William Hall Award, serves as peer reviewer, occasional session chair, and officer of the Biomaterials & Medical Products Commercialization SIG. He has over 30 publications including two chapters on silicones in the Ratner et al. text, Biomaterials Science: An Introduction to Materials in Medicine. Jim is a graduate of Cooper Union in New York City where he earned his undergraduate and master degrees in Engineering. Jim has worked in the medical device field for over 35 years. Prior to joining Dow Corning in 1986, Jim was Associate Director of Technology and Director of Quality Assurance at Tyndale Plains-Hunter, Ltd., a firm that specialized in hydrophilic polyurethanes for medical applications. Jim’s current responsibilities at Dow include assessment of emerging medical technologies and product development/commercialization; as well as investigation of legacy medical device-associated issues. An inventor on several patents, Jim helped develop a number of Dow Corning medical devices. He served as product steward for hospital/surgical products, and contributed to Dow Corning’s regulatory submissions.